Stayble Therapeutics’ board proposes voluntary liquidation and delisting
The shareholders in the research company Stayble Therapeutics are called to an extraordinary general meeting, which also serves as the first control meeting, on Thursday, May 7 in Gothenburg. The company has, as previously announced, prepared a control balance sheet, which has been reviewed by the company’s auditor. The control balance sheet shows that equity…

